Table 2.
Drug | Populations studied | Effects | Recommendations |
---|---|---|---|
Morphine96,112 | Adult, infant, animal | ↓Clearance | Consider lower starting dose, Conservative dose titration |
↑Serum concentrations | |||
Potential for decreased efficacy | |||
Fentanyl97,113 | Adult, animal | Drug sequestration in periphery | Consider lower starting dose |
↓Volume of distribution | Conservative dose titration | ||
↓Clearance | Monitor for increased response during rewarming | ||
↑Serum concentrations | |||
Midazolam95 | Adult | ↓Clearance | Consider lower starting dose |
↑Volume of distribution | Conservative dose titration | ||
↑Serum concentrations | Monitor for withdrawal or seizures during rewarming | ||
Vecuronium98,114 | Adult, infant | ↓Clearance | Use lowest effective dose |
Consider periodic discontinuation to allow for movement | |||
Phenobarbital99 | Child, infant | ↓Hepatic metabolism | Monitor serum concentrations and adjust as needed |
↑Excretion of unchanged drug | |||
Phenytoin102,103 | Adult, infant | ↓Clearance | Consider lower starting dose |
↑Serum concentrations | Monitor serum concentrations and adjust as needed | ||
Dosage adjustment may be needed during rewarming | |||
Topiramate104 | Infant | Longer time to max concentration | Once-daily dosing recommended |
↓Clearance | |||
↑Serum concentrations | |||
Gentamicin106,115,116 | Infant, animal | ↓Clearance with renal dysfunction | Consider lower starting dose |
↑Serum concentrations |
↓ decreased; ↑ increased.